159 related articles for article (PubMed ID: 19784757)
1. Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.
Shetty P; Velusamy T; Bhandary YP; Liu MC; Shetty S
Mol Cell Biochem; 2010 Feb; 335(1-2):235-47. PubMed ID: 19784757
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
[TBL] [Abstract][Full Text] [Related]
3. Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity.
Shetty S; Ganachari M; Liu MC; Azghani A; Muniyappa H; Idell S
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L591-8. PubMed ID: 15951330
[TBL] [Abstract][Full Text] [Related]
4. Regulation of urokinase receptor expression by protein tyrosine phosphatases.
Shetty S; Velusamy T; Idell S; Tang H; Shetty PK
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L414-21. PubMed ID: 17028265
[TBL] [Abstract][Full Text] [Related]
5. Regulation of urokinase receptor expression by phosphoglycerate kinase.
Shetty S; Muniyappa H; Halady PK; Idell S
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):100-6. PubMed ID: 14764427
[TBL] [Abstract][Full Text] [Related]
6. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
[TBL] [Abstract][Full Text] [Related]
7. Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells.
Shetty S; Idell S
Am J Respir Cell Mol Biol; 2004 Jan; 30(1):69-75. PubMed ID: 12816732
[TBL] [Abstract][Full Text] [Related]
8. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
[TBL] [Abstract][Full Text] [Related]
9. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.
Tang H; Kerins DM; Hao Q; Inagami T; Vaughan DE
J Biol Chem; 1998 Jul; 273(29):18268-72. PubMed ID: 9660790
[TBL] [Abstract][Full Text] [Related]
10. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
[TBL] [Abstract][Full Text] [Related]
11. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
12. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
[TBL] [Abstract][Full Text] [Related]
13. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
15. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
Huang S; New L; Pan Z; Han J; Nemerow GR
J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells.
Bhat GJ; Gunaje JJ; Idell S
Am J Physiol; 1999 Aug; 277(2):L301-9. PubMed ID: 10444524
[TBL] [Abstract][Full Text] [Related]
18. Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction.
Ploug M; Rahbek-Nielsen H; Ellis V; Roepstorff P; Danø K
Biochemistry; 1995 Oct; 34(39):12524-34. PubMed ID: 7548000
[TBL] [Abstract][Full Text] [Related]
19. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
[TBL] [Abstract][Full Text] [Related]
20. Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.
Cunningham O; Campion S; Perry VH; Murray C; Sidenius N; Docagne F; Cunningham C
Glia; 2009 Dec; 57(16):1802-14. PubMed ID: 19459212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]